Systematic Ambulatory ECG Monitoring Following TAVI
Condition: Aortic Stenosis · Conduction Disturbances · Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
About this study
This multicenter, prospective, randomized superiority trial will evaluate whether systematic 14-day ambulatory ECG monitoring following hospital discharge after transcatheter aortic valve implantation (TAVI) reduces the risk of sudden death, symptomatic arrhythmic events, or stroke within 1 year compared with standard post-discharge care. Patients undergoing successful TAVI without permanent pacemaker implantation and presenting with at least one ECG conduction abnormality at hospital discharge will be randomized to receive either ambulatory ECG monitoring or standard follow-up. All participants will undergo routine clinical follow-up at 30 days and 1 year after TAVI.
This description comes directly from the study's public registry record.
Talk to the study team
Josep Rodes-Cabau, MD, PhD · 14186568711 · josep.rodes-cabau@criucpq.ulaval.ca
Emilie Pelletier Beaumont, MSc · 4186568711 · emilie.pelletier-beaumont@criucpq.ulaval
Always discuss trial participation with your own doctor first.
Locations (1)
| Institut universitaire de cardiologie et de pneumologie de Québec - UL | Québec, Quebec, Canada | — |
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07739316